Generics 45

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Isoxsuprine manufacturers

45 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

45 products found

isoxsuprine

Tablets, sustained release (SR) 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #17708
This pharmaceutical company boasts over 75 years of experience in manufacturing, research & development, and global supply chain management for specialty pharmaceuticals. They have introduced over 100 unique molecules to the Indian market and hold prominent positions in 9 therapeutic segments across regions including the EU and North America. Their product portfolio is extensive, encompassing injectables, antibiotics, antifungals, antipyretics, cardiovascular medications, central nervous system drugs, corticosteroids, gastrointestinal treatments, and nutraceuticals. They also offer pediatric formulations and vaccines. The company emphasizes quality, affordability, and innovation, reflected in their GMP certifications and numerous product patents. Their key therapeutic areas include infectious diseases, pain management, cardiology, and pediatrics, with principal dosage forms ranging from oral solutions to injections.

Manufacturer usually replies in 4 days

isoxsuprine

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #17708
This pharmaceutical company boasts over 75 years of experience in manufacturing, research & development, and global supply chain management for specialty pharmaceuticals. They have introduced over 100 unique molecules to the Indian market and hold prominent positions in 9 therapeutic segments across regions including the EU and North America. Their product portfolio is extensive, encompassing injectables, antibiotics, antifungals, antipyretics, cardiovascular medications, central nervous system drugs, corticosteroids, gastrointestinal treatments, and nutraceuticals. They also offer pediatric formulations and vaccines. The company emphasizes quality, affordability, and innovation, reflected in their GMP certifications and numerous product patents. Their key therapeutic areas include infectious diseases, pain management, cardiology, and pediatrics, with principal dosage forms ranging from oral solutions to injections.

Manufacturer usually replies in 4 days

isoxsuprine

Tablets 10 mg, 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
MAs for sale
India
Manufacturer #22627
This pharmaceutical company was founded in 2007 and has two manufacturing facilities strategically located in India. They boast over 1,800 products spanning a range of therapeutic areas, including those focused on dermatology, pain management, and possibly central nervous system disorders based on the listed divisions. The company produces both prescription medications and over-the-counter drugs, utilizing diverse dosage forms such as tablets and capsules. They maintain a strong national network for distribution and a global presence. GMP certifications are likely held due to their focus on quality manufacturing practices.

Manufacturer usually replies in 4 days

Want to see all 45 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation